We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Simple Bile Acid Blood Test Predicts Stillbirth Risk

By LabMedica International staff writers
Posted on 25 Feb 2019
Print article
Image: The bile acid blood test is used to predict stillbirth risk (Photo courtesy of bluehorizon).
Image: The bile acid blood test is used to predict stillbirth risk (Photo courtesy of bluehorizon).
Intrahepatic cholestasis of pregnancy (ICP) is caused by a build-up of bile acids in the blood, and symptoms include pruritus. ICP is a liver disorder affecting approximately 5,300 pregnancies annually in the UK, more than 14 every day.

ICP is diagnosed in women with gestational pruritus and increased serum bile acids, and can be complicated by preterm labor, fetal asphyxia, meconium-stained amniotic fluid, and stillbirth. It was previously thought that small increases in bile acid concentration are associated with higher risks of stillbirth. Pregnant women showing symptoms of ICP, therefore, are often offered early induction of labor at around 37 weeks in order to prevent stillbirth.

A large team of international scientists collaborating with Kings College London (London, UK) analyzed more than 170,000 pregnancies from 40 international studies to understand the link between ICP, bile acid levels and stillbirth. The results of the study show that for the majority of women with ICP, who have bile acid concentration below 100 μmol/, the risk of stillbirth is not significantly greater than that of pregnant women without ICP. This means they need no further treatment other than regular bile acid blood tests for the remainder of their pregnancy.

The scientists reported that stillbirth occurred in 45/4,936 (0.83%) of intrahepatic cholestasis of pregnancy cases and 519/163,947 (0.32%) of control pregnancies (odds ratio [OR] 1.46). In singleton pregnancies, stillbirth was associated with maximum total bile acid concentration (area under the receiver operating characteristic curve [ROC AUC] 0.83), but not alanine aminotransferase (ROC AUC 0·46). For singleton pregnancies, the prevalence of stillbirth was 3/2,310 (0.13%) of intrahepatic cholestasis of pregnancy cases in women with serum total bile acids of less than 40 μmol/L versus 4/1,412 (0.28%) of cases with total bile acids of 40–99 μmol/L (hazard ratio [HR] 2.35), and versus 18/524 (3.44%) of cases for bile acids of 100 μmol/L or more (HR 30.5).

Caroline Ovadia, BCh, a Clinical Lecturer and first author of the study, said, “This marks a real step forward in the diagnosis and management of liver disorders during pregnancy. Being able to measure the risks to women and their babies by simple tests allows doctors to concentrate treatment on those who really need it. It also means that women will not have to be offered preterm birth unnecessarily which comes with associated risks to their babies including admission to neonatal units, breathing problems and jaundice.” The study was published on February 14, 2019, in the journal The Lancet.

Related Links:
Kings College London

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.